Archive for the Immunotherapy Category

Provectus (PVCT) Entered Into Mentor Capital Cancer Immunotherapy …

Provectus Pharmaceuticals, Inc. (PVCT), which develops cancer drugs similar to Dendreon Corporation (DNDN) or Genta Incorporated (GETA), has been entered into the Cancer Immunotherapy Index created by Mike Havrilla, …

New Mesothelioma Treatment – A 2010 Space Odyssey

Mesothelioma cancer is a form of cancer that has been linked to asbestos exposure and can affect the lungs, abdomen and the heart.

Immunotherapy mesothelioma treatment developed in Holland …

Immunotherapy techniques, if proven sufficiently effective in destroying cancer cells, will bring a great change to current cancer treatments and could vastly improve the prognosis of diseases like mesothelioma.

Cytokine Immunotherapy of Cancer | My New Therapy

Multikine®, is an immunotherapeutic agent being developed as a first-line treatment for cancer , composed of a mixture of cytokines that both kills cancer cells.

Natural Cancer Treatment Vs Conventional Cancer Treatment | No …

The role of this article is to summarize the main side effects caused by different types of conventional cancer treatments and potential natural treatment (including nutrition, remedies and immunotherapy ). …

Prostate Cancer Immunotherapy | My New Therapy

Multicenter, Open Label, Phase 2 Study of Sipuleucel-T in Men with Metastatic Castrate Resistant Prostate Cancer (CRPC). Autologous dendritic cells loaded.

Scrip News – Novartis takes option on Transgene's lung cancer …

Transgene of France has signed an exclusive option agreement with Novartis for the development and commercialisation of the targeted immunotherapy product TG4010 for the first-line treatment of non-small cell lung cancer (NSCLC) and …

Genetic Therapy Protocols of Assets Part II « Cancer Theraphy Blog

e) Genetic immunotherapy .

Argos Therapeutics Presents Positive Phase 2 Data of its Arcelis …

DURHAM, N.C.–(BUSINESS WIRE)–Mar 8, 2010 – Argos Therapeutics today announced the presentation of positive data from a Phase 2 trial that evaluated the safety, clinical response and immune response of AGS-003 treatment in newly … Argos is an immunotherapy company developing new treatments for cancer , infectious and autoimmune diseases, and transplantation rejection. The Company has generated multiple platform technologies and a diverse pipeline of products based on …

bowel cancer | Cancer Research

Treatment . Surgery – Surgery is an operation that involves removal of cancerous part of the colon. It acts as a primary treatment for colon cancer